Condition
Arterial Thromboembolism clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Arterial Thromboembolism clinical trials that are recruiting, at sites in 6 countries (most in China (2), Hong Kong (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Arterial Thromboembolism clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Aspiration thrombectomy with the Symphony or Prodigy devices | — | Huntsville, Alabama and 12 other locations | Recruiting | Jan 20, 2026 |
| Predicting thrombosis risk in lung cancer patients on immune therapy | — | Zhengzhou, Henan and 4 other locations | Recruiting | Apr 30, 2025 |
| Observational study of blood clotting and bleeding disorders in Chinese patients | — | Beijing, Beijing Municipality and 4 other locations | Recruiting | Dec 11, 2024 |
| Confirming the safety and performance of a new embolectomy catheter | — | Genk and 2 other locations | Recruiting | May 23, 2022 |
| Evaluating DOAC levels in Chinese patients with atrial fibrillation | — | Hong Kong | Recruiting | May 17, 2022 |
All recruiting trials (5)
-
Aspiration thrombectomy with the Symphony or Prodigy devices
This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.
-
Predicting thrombosis risk in lung cancer patients on immune therapy
This study is trying to see if certain factors can help predict the risk of blood clots in lung cancer patients receiving immune therapy.
-
Observational study of blood clotting and bleeding disorders in Chinese patients
This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.
-
Confirming the safety and performance of a new embolectomy catheter
This study is testing a new catheter to see if it safely and effectively helps patients who need surgery to remove blood clots when other treatments haven't worked for them.
-
Evaluating DOAC levels in Chinese patients with atrial fibrillation
This study is testing how stopping blood-thinning medication for a short time affects Chinese patients with atrial fibrillation to see if it's safe for them during medical procedures.
Related topics
Quick answers
How many Arterial Thromboembolism clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (2 trials), Hong Kong (1 trial), United States (1 trial), Belgium (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.